Is the Neutrophil to Lymphocyte Ratio Associated with Liver Fibrosis in Patients with Chronic Hepatitis B?
Overview
Affiliations
Aim: To determine the association between the neutrophil to lymphocyte (N/L) ratio and the degree of liver fibrosis in patients with chronic hepatitis B (CHB) infection.
Methods: Between December 2011 and February 2013, 129 consecutive CHB patients who were admitted to the study hospitals for histological evaluation of chronic hepatitis B-related liver fibrosis were included in this retrospective study. The patients were divided into two groups based on the fibrosis score: individuals with a fibrosis score of F0 or F1 were included in the "no/minimal liver fibrosis" group, whereas patients with a fibrosis score of F2, F3, or F4 were included in the "advanced liver fibrosis" group. The Statistical Package for Social Sciences 18.0 for Windows was used to analyze the data. A P value of < 0.05 was accepted as statistically significant.
Results: Three experienced and blinded pathologists evaluated the fibrotic status and inflammatory activity of 129 liver biopsy samples from the CHB patients. Following histopathological examination, the "no/minimal fibrosis" group included 79 individuals, while the "advanced fibrosis" group included 50 individuals. Mean (N/L) ratio levels were notably lower in patients with advanced fibrosis when compared with patients with no/minimal fibrosis. The mean value of the aspartate aminotransferase-platelet ratio index was markedly higher in cases with advanced fibrosis compared to those with no/minimal fibrosis.
Conclusion: Reduced levels of the peripheral blood N/L ratio were found to give high sensitivity, specificity and predictive values in CHB patients with significant fibrosis. The prominent finding of our research suggests that the N/L ratio can be used as a novel noninvasive marker of fibrosis in patients with CHB.
RDW Predicts Fibrosis in Patients with Chronic Hepatitis B Having Persistently Normal ALT Levels.
Guller B, Gulumsek E, Sumbul H, Avci B, Tas A Ethiop J Health Sci. 2024; 33(4):591-600.
PMID: 38784205 PMC: 11111190. DOI: 10.4314/ejhs.v33i4.5.
Liu Y, Xie S, Zhou J, Cai Y, Zhang P, Li J Sci Rep. 2024; 14(1):11485.
PMID: 38769391 PMC: 11106071. DOI: 10.1038/s41598-024-62521-1.
Polewczyk M, Jachec W, Szczesniak-Stanczyk D, Polewczyk A, Tomaszewski A, Brzozowski W J Clin Med. 2023; 12(23).
PMID: 38068550 PMC: 10707215. DOI: 10.3390/jcm12237498.
Bannaga A, Arasaradnam R World J Gastroenterol. 2020; 26(33):5022-5049.
PMID: 32952347 PMC: 7476180. DOI: 10.3748/wjg.v26.i33.5022.
Ruta V, Man A, Alexescu T, Motoc N, Tarmure S, Ungur R Medicina (Kaunas). 2020; 56(8).
PMID: 32751302 PMC: 7466218. DOI: 10.3390/medicina56080381.